The Medicines Company to Buy Incline Therapeutics
The Medicines Company, a publicly traded company, will buy Incline Therapeutics Inc., a company developing a compact, disposable, needleless Patient-Controlled Analgesia system for the short-term management of acute postoperative pain. The Medicines Company has agreed to pay $185 million in an upfront payment, with additional payments if certain regulatory and commercial milestones are met. Redwood City, Calif.-based Incline is backed by investors including Frazier Healthcare Ventures, 5AM Ventures, Technology Partners, Adams Street Partners, and Saints Capital.
12 December 2012•4 mins read
